SPDR S&P Biotech ETF Newsroom

Drugs Not Selected for Medicare Price Negotiation Nearly Doubled - Report

Seeking Alpha00:35

Peering Into Biogen's Recent Short Interest

Benzinga00:00

Novo, Eli Lilly to Dominate Global Pharma Sales in 2025: Report

Seeking AlphaJan 9 21:56

Alger Launches Russell Innovation ETF To Capitalize On Emerging Innovators

BenzingaJan 9 03:32

Solid Biosciences Outpaces Competitors In Duchenne Gene Therapy Development

BenzingaJan 9 03:09

Galapagos Unveils 2025 Split To Accelerate Innovation, Sharpen Strategic Focus

BenzingaJan 9 03:07

Assessing AbbVie: Insights From 17 Financial Analysts

BenzingaJan 9 03:00

Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies

BenzingaJan 9 01:54

8 Health Care Stocks Whale Activity In Today's Session

BenzingaJan 9 01:35

Moderna Analyst Ratings

BenzingaJan 8 23:03 · Ratings

Neurocrine Biosciences Analyst Ratings

BenzingaJan 8 23:00 · Ratings

United Therapeutics Analyst Ratings

BenzingaJan 8 22:59 · Ratings

Compugen Announced That The First Patient Was Dosed In A Phase 1 Clinical Trial With Com503, A Potential First-in-class Antibody Against Il-18 Binding Protein Licensed By Compugen To Gilead

BenzingaJan 8 20:04

Biogen Analyst Ratings

BenzingaJan 8 19:43 · Ratings

AbbVie Analyst Ratings

BenzingaJan 8 19:39 · Ratings

Nvidia, Palantir, Ionq, Novavax, And Tesla: Why These 5 Stocks Are On Investors' Radars Today

BenzingaJan 8 10:16

Solid Biosciences Stock Jumps 11% Post-market on FDA Update

Seeking AlphaJan 8 06:23

Arbutus Could Benefit From Big Pharma Bird Flu Vaccines: Jefferies

Seeking AlphaJan 8 03:58

Stocks Sink As Bond Yields Soar, Nvidia Eyes Worst Day In 4 Months, Bitcoin Tumbles To $97,000: What's Driving Markets Tuesday?

BenzingaJan 8 02:10

Looking Into Gilead Sciences's Recent Short Interest

BenzingaJan 8 02:00